KPV
KPV is the C-terminal tripeptide fragment of alpha-MSH (lysine-proline-valine), understood to modulate inflammatory signaling without the pigmentary effects of the parent hormone. Physicians consider it for supporting a balanced inflammatory response at mucosal and tissue interfaces, where clinically appropriate.
- Personalized guidance, one-on-one with your care team.
- If a physician determines it isn't the right fit, you pay nothing.
$251 / month
Same vial, shipped monthly — a lower rate for staying under continuing physician care. Skip or cancel anytime.
Cancel or pause anytime · Ships only after physician approval
You complete a secure medical intake first. A licensed U.S. physician reviews it — typically within 24 to 48 hours — and you are only charged once a physician approves your protocol. Each completed screening remains valid for 12 months. See how it works · Meet our physicians
Mechanism of action
How KPV works at the receptor, signaling, neural, and regulatory levels — shared to inform, never to promise an outcome. Your physician confirms what is appropriate for you.
Receptor Activation
As the minimal active fragment of alpha-melanocyte-stimulating hormone, KPV is understood to touch melanocortin signaling, though much of its activity appears to occur through melanocortin-receptor-independent routes after intracellular uptake. It is understood to be transported via the peptide transporter PepT1 on epithelial and immune cells, which is linked to its localization at sites of inflammation. Its binding behavior appears distinct from the full alpha-MSH molecule, which is thought to underlie its lack of pigment-related effects.
Cell Signaling
KPV is understood to downregulate pro-inflammatory NF-kB signaling and to reduce activation of MAP kinase cascades. This appears to be accompanied by attenuated transcription of inflammatory mediators such as certain interleukins and TNF-alpha. The net effect is a dampening of intracellular signals that amplify the inflammatory program, rather than broad immune suppression.
Neural Activity
Limited direct neural activity is described for KPV; it lacks the central melanocortin actions on appetite and pigmentation that characterize larger MSH-derived peptides. Any relevance to neural signaling is generally understood in terms of neuro-immune crosstalk at peripheral and mucosal tissues rather than primary CNS effects.
Regulatory Pathways
KPV is understood chiefly in the context of immune and mucosal regulation, where it is associated with a more balanced cytokine milieu and supported epithelial barrier integrity. Its PepT1-mediated delivery has drawn attention to gastrointestinal and dermal contexts. These effects are modulatory and homeostatic in nature, not a treatment for any specific condition.
Built around you, never one-size-fits-all
Who it's for
A physician may consider KPV for adults interested in supporting a balanced inflammatory and mucosal-recovery response as part of a supervised wellness protocol.
What's included
Each order includes one 10mg (10mL) KPV vial preparation, a physician evaluation of your eligibility, and personalized guidance on appropriate use.
Ongoing care
Your physician stays involved beyond the first order — check-ins, dose guidance, and refills under continuing supervision.
Prescribed, compounded, supervised.
This is not a research chemical bought from an anonymous importer. Every therapy is prescribed by a licensed physician and compounded for you by a licensed U.S. pharmacy — American-made, on your order.
- Compounded by licensed U.S. pharmacies to USP standards
- Compounded by a licensed U.S. pharmacy on your prescription
- Reviewed and prescribed by U.S.-licensed physicians
- Cold-chain handling and discreet, tracked delivery
Related therapies
Begin KPV with a physician evaluation
One honest price, evaluation included. A licensed physician reviews your case before anything ships — with a full refund if it isn't the right fit.